Tap to start →
Photo: Mockup Graphics / Unsplash
1 / 6
The honest answer has two parts: the trial numbers, and what fits your life.
2 / 6
Zepbound 15 mg averaged 20.9% weight loss over 72 weeks in SURMOUNT-1.
3 / 6
Wegovy averaged 14.9% in STEP 1 and is also approved to lower heart risk.
4 / 6
In SURMOUNT-5, tirzepatide averaged about 20.2% vs about 13.7% for semaglutide.
5 / 6
Coverage, side effects and shot vs pill all matter as much as the number.
6 / 6
Project your own loss, then talk it through with a licensed clinician.
Zepbound, Wegovy, the Wegovy pill and Saxenda compared by trial results, side effects and routine, and why the best GLP-1 depends on you.
Tap below for the full page. Not medical advice; talk to your clinician about your care.